Interventions of Interest:
- atidarsagene autotemcel (“arsa-cel”, Orchard Therapeutics)
For questions please contact Kelsey Gosselin, Program Manager, at kgosselin@icer.org.
View the Key Stakeholder List.
Assessment Status
Open
Upcoming Milestone
Revised Scoping DocumentView
Interventions of Interest:
For questions please contact Kelsey Gosselin, Program Manager, at kgosselin@icer.org.
View the Key Stakeholder List.
CTAF
The CTAF’s 2023 public meeting on metachromatic leukodystrophy.
Public Comment Period
See Full TimelinePlease find the Research Protocol here:
Please find the Model Analysis Plan here:
Public Comments
OpenView
Closed